85 related articles for article (PubMed ID: 20374043)
1. Evaluation of a panel of circulating DNA, RNA and protein potential markers for pathologies of pregnancy.
Galbiati S; Causarano V; Pinzani P; Francesca S; Orlando C; Smid M; Pasi F; Castiglioni MT; Cavoretto P; Rovere-Querini P; Pedroni S; Calza S; Ferrari M; Cremonesi L
Clin Chem Lab Med; 2010 Jun; 48(6):791-4. PubMed ID: 20374043
[TBL] [Abstract][Full Text] [Related]
2. First trimester PTX3 levels in women who subsequently develop preeclampsia and fetal growth restriction.
Cetin I; Cozzi V; Papageorghiou AT; Maina V; Montanelli A; Garlanda C; Thilaganathan B
Acta Obstet Gynecol Scand; 2009; 88(7):846-9. PubMed ID: 19544202
[TBL] [Abstract][Full Text] [Related]
3. The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia.
Ng EK; Leung TN; Tsui NB; Lau TK; Panesar NS; Chiu RW; Lo YM
Clin Chem; 2003 May; 49(5):727-31. PubMed ID: 12709362
[TBL] [Abstract][Full Text] [Related]
4. Minimal alteration in the ratio of circulatory fetal DNA to fetal corticotropin-releasing hormone mRNA level in preeclampsia.
Zhong XY; Holzgreve W; Gebhardt S; Hillermann R; Tofa KC; Gupta AK; Huppertz B; Hahn S
Fetal Diagn Ther; 2006; 21(3):246-9. PubMed ID: 16601331
[TBL] [Abstract][Full Text] [Related]
5. Cell-free mRNA concentrations of CRH, PLAC1, and selectin-P are increased in the plasma of pregnant women with preeclampsia.
Purwosunu Y; Sekizawa A; Farina A; Wibowo N; Okazaki S; Nakamura M; Samura O; Fujito N; Okai T
Prenat Diagn; 2007 Aug; 27(8):772-7. PubMed ID: 17554801
[TBL] [Abstract][Full Text] [Related]
6. [Adrenocorticotropin hormone--possible marker of pregnancy pathologies].
Hodická Z; Bienertová-Vasků J; Ventruba P; Vasků A
Ceska Gynekol; 2012 Apr; 77(2):142-4. PubMed ID: 22702072
[TBL] [Abstract][Full Text] [Related]
7. Complex expression changes of the placental endothelin system in early and late onset preeclampsia, fetal growth restriction and gestational diabetes.
Dieber-Rotheneder M; Beganovic S; Desoye G; Lang U; Cervar-Zivkovic M
Life Sci; 2012 Oct; 91(13-14):710-5. PubMed ID: 22580289
[TBL] [Abstract][Full Text] [Related]
8. Serum Pentraxin 3 is associated with signs of arterial alteration in women with preeclampsia.
Akhter T; Wikström AK; Larsson M; Larsson A; Wikström G; Naessen T
Int J Cardiol; 2017 Aug; 241():417-422. PubMed ID: 28377191
[TBL] [Abstract][Full Text] [Related]
9. [Expression of pentraxin-3 in placentas and its relationship with severe preeclampsia].
Zhou P; Luo X; Qi HB
Zhonghua Fu Chan Ke Za Zhi; 2012 May; 47(5):347-50. PubMed ID: 22883522
[TBL] [Abstract][Full Text] [Related]
10. PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR.
Cozzi V; Garlanda C; Nebuloni M; Maina V; Martinelli A; Calabrese S; Cetin I
Placenta; 2012 Dec; 33(12):1039-44. PubMed ID: 23062219
[TBL] [Abstract][Full Text] [Related]
11. Circulating RNA coding genes regulating apoptosis in maternal blood in severe early onset fetal growth restriction and pre-eclampsia.
Whitehead CL; Walker SP; Lappas M; Tong S
J Perinatol; 2013 Aug; 33(8):600-4. PubMed ID: 23429544
[TBL] [Abstract][Full Text] [Related]
12. [The predictive value of plasma fibronectin concentration on fetal growth retardation and preeclampsia at earlier stage of the third trimester].
Xiong G; Wang Z; Yu Q
Zhonghua Fu Chan Ke Za Zhi; 2001 Dec; 36(12):734-7. PubMed ID: 16136894
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of adiponectin and leptin at 23-25 weeks of pregnancy in women with impaired placentation and in those with established fetal growth restriction.
Savvidou MD; Sotiriadis A; Kaihura C; Nicolaides KH; Sattar N
Clin Sci (Lond); 2008 Oct; 115(7):219-24. PubMed ID: 18211260
[TBL] [Abstract][Full Text] [Related]
14. Parallel assessment of circulatory fetal DNA and corticotropin-releasing hormone mRNA in early- and late-onset preeclampsia.
Zhong XY; Gebhardt S; Hillermann R; Tofa KC; Holzgreve W; Hahn S
Clin Chem; 2005 Sep; 51(9):1730-3. PubMed ID: 16120955
[No Abstract] [Full Text] [Related]
15. Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls.
Farina A; Sekizawa A; Purwosunu Y; Rizzo N; Banzola I; Concu M; Morano D; Giommi F; Bevini M; Mabrook M; Carinci P; Okai T
Prenat Diagn; 2006 Dec; 26(12):1115-20. PubMed ID: 16952198
[TBL] [Abstract][Full Text] [Related]
16. Circulating corticotropin-releasing hormone mRNA in maternal plasma: relationship with gestational age and severity of preeclampsia.
Farina A; Chan CW; Chiu RW; Tsui NB; Carinci P; Concu M; Banzola I; Rizzo N; Lo YM
Clin Chem; 2004 Oct; 50(10):1851-4. PubMed ID: 15388664
[No Abstract] [Full Text] [Related]
17. Elevation of plasma levels of the long pentraxin 3 precedes preeclampsia in pregnant patients with type 1 diabetes.
Castiglioni MT; Scavini M; Cavallin R; Pasi F; Rosa S; Sabbadini MG; Rovere-Querini P
Autoimmunity; 2009 May; 42(4):296-8. PubMed ID: 19811281
[TBL] [Abstract][Full Text] [Related]
18. Plasma and tissue expression of the long pentraxin 3 during normal pregnancy and preeclampsia.
Rovere-Querini P; Antonacci S; Dell'Antonio G; Angeli A; Almirante G; Cin ED; Valsecchi L; Lanzani C; Sabbadini MG; Doglioni C; Manfredi AA; Castiglioni MT
Obstet Gynecol; 2006 Jul; 108(1):148-55. PubMed ID: 16816069
[TBL] [Abstract][Full Text] [Related]
19. A strategy for identifying circulating placental RNA markers for fetal growth assessment.
Pang WW; Tsui MH; Sahota D; Leung TY; Lau TK; Lo YM; Chiu RW
Prenat Diagn; 2009 May; 29(5):495-504. PubMed ID: 19226523
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of RASSF1A cell-free DNA as a biomarker of pre-eclampsia.
Salvianti F; Inversetti A; Smid M; Valsecchi L; Candiani M; Pazzagli M; Cremonesi L; Ferrari M; Pinzani P; Galbiati S
Placenta; 2015 Sep; 36(9):996-1001. PubMed ID: 26183647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
